MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00020579 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

75

Enrollment

NIH

Sponsor class

Conditions

Cancer

Interventions

DRUG: entinostat

Sponsor

National Institutes of Health Clinical Center (CC)

Collaborators

[object Object]